Pretty bizarre...it was a post regarding the number of analysts that cover Vivitar's parent company, which lends discussion as to who is seeing this story develop and if and when they will take notice...multipled by 174+, as we well know, the greater exposure of this story, interest generates dramatically due to the nature of the huge product categories at stake.

Why that would warrant a deletion only Agora knows for sure....lol.